Co-Authors
This is a "connection" page, showing publications co-authored by Biji Mathew and Steven Roth.
Connection Strength
4.378
-
MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders: Engineered extracellular vesiclesand retinal ischemia. Acta Biomater. 2023 03 01; 158:782-797.
Score: 0.915
-
Uptake and Distribution of Administered Bone Marrow Mesenchymal Stem Cell Extracellular Vesicles in Retina. Cells. 2021 03 25; 10(4).
Score: 0.808
-
Autophagy and post-ischemic conditioning in retinal ischemia. Autophagy. 2021 06; 17(6):1479-1499.
Score: 0.762
-
Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion. Biomaterials. 2019 03; 197:146-160.
Score: 0.693
-
Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats. Graefes Arch Clin Exp Ophthalmol. 2017 Aug; 255(8):1581-1592.
Score: 0.618
-
Emerging concepts in the treatment of optic neuritis: mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther. 2021 Dec 04; 12(1):594.
Score: 0.212
-
Gene expression in retinal ischemic post-conditioning. Graefes Arch Clin Exp Ophthalmol. 2018 May; 256(5):935-949.
Score: 0.163
-
Hypoxic-Preconditioned Bone Marrow Stem Cell Medium Significantly Improves Outcome After Retinal Ischemia in Rats. Invest Ophthalmol Vis Sci. 2016 06 01; 57(7):3522-32.
Score: 0.145
-
Neuroprotective and Anti-Inflammatory Activities of Hybrid Small-Molecule SA-10 in Ischemia/Reperfusion-Induced Retinal Neuronal Injury Models. Cells. 2024 Feb 25; 13(5).
Score: 0.062